Research Sample Repository for Hematopoietic Cell Transplantation, Cellular Therapies, and Marrow Toxic Injuries

What this Trial Is About

Researchers are establishing a Research Sample Repository to collect blood samples related to histocompatibility and hematopoietic cell transplantation HCT or other cellular therapies. This repository supports research aimed at understanding molecular factors affecting transplant outcomes, studying tissue type distributions, and evaluating the success of transplantation and supportive care in marrow toxic injuries. The research includes anonymous studies and aims to facilitate broader scientific investigations in these areas. The repository accepts samples from four main groups donors of hematopoietic cells or other cellular therapies, cord blood units used in treatment, recipients of hematopoietic cell transplants or cellular therapies, and patients treated for marrow toxic injuries. Samples come from donors who have donated or plan to donate cells, cord blood units infused at treatment centers, transplant or therapy recipients, and marrow toxic injury patients receiving various treatments including supportive care or stem cell transplants. Participants contribute samples that are made available to researchers for various analyses including genomic and biomolecular studies. The primary goal is to provide blood samples for research related to histocompatibility and transplantation outcomes. Participation includes adults and children with or without decision-making capacity. The repository facilitates access to these samples for approved research, supporting studies from multiple centers and investigators over an extended period.

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries